Imperva Inc (IMPV) Stock Rating Lowered by Wells Fargo & Company

Imperva Inc (NYSE:IMPV) was downgraded by equities research analysts at Wells Fargo & Company from an “outperform” rating to a “market perform” rating in a report issued on Monday.

IMPV has been the subject of several other reports. Zacks Investment Research upgraded shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $52.00 price objective for the company in a report on Wednesday, August 2nd. Evercore ISI set a $56.00 price objective on shares of Imperva and gave the stock a “buy” rating in a report on Friday, July 28th. BidaskClub upgraded shares of Imperva from a “sell” rating to a “hold” rating in a report on Tuesday, August 22nd. Piper Jaffray Companies set a $58.00 price objective on shares of Imperva and gave the stock a “buy” rating in a report on Monday, August 28th. Finally, Monness Crespi & Hardt raised their price objective on shares of Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a report on Friday, July 28th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. Imperva currently has a consensus rating of “Hold” and a consensus price target of $52.34.

Shares of Imperva (IMPV) opened at 42.95 on Monday. The company has a 50-day moving average price of $44.09 and a 200-day moving average price of $45.85. Imperva has a 12 month low of $34.40 and a 12 month high of $57.24. The company’s market capitalization is $1.45 billion.

Imperva (NYSE:IMPV) last issued its quarterly earnings data on Thursday, July 27th. The software maker reported ($0.10) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.05 by ($0.15). Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The company had revenue of $74.44 million during the quarter, compared to analysts’ expectations of $74.30 million. During the same quarter last year, the business earned ($0.23) earnings per share. The business’s quarterly revenue was up 28.6% on a year-over-year basis. On average, equities analysts anticipate that Imperva will post $0.81 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This article was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://ledgergazette.com/2017/10/11/imperva-inc-impv-stock-rating-lowered-by-wells-fargo-company.html.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of the firm’s stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the sale, the director now owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.20% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in IMPV. ETF Managers Group LLC bought a new stake in shares of Imperva during the second quarter valued at approximately $41,888,000. North Run Capital LP increased its position in shares of Imperva by 999.3% during the first quarter. North Run Capital LP now owns 750,000 shares of the software maker’s stock valued at $30,788,000 after acquiring an additional 681,772 shares in the last quarter. Clearbridge Investments LLC increased its position in shares of Imperva by 47.0% during the first quarter. Clearbridge Investments LLC now owns 1,262,507 shares of the software maker’s stock valued at $51,826,000 after acquiring an additional 403,809 shares in the last quarter. BlackRock Inc. increased its position in shares of Imperva by 11.3% during the second quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock valued at $101,635,000 after acquiring an additional 215,170 shares in the last quarter. Finally, Eagle Asset Management Inc. increased its position in shares of Imperva by

IMPV has been the subject of several other reports. Zacks Investment Research upgraded shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $52.00 price objective for the company in a report on Wednesday, August 2nd. Evercore ISI set a $56.00 price objective on shares of Imperva and gave the stock a “buy” rating in a report on Friday, July 28th. BidaskClub upgraded shares of Imperva from a “sell” rating to a “hold” rating in a report on Tuesday, August 22nd. Piper Jaffray Companies set a $58.00 price objective on shares of Imperva and gave the stock a “buy” rating in a report on Monday, August 28th. Finally, Monness Crespi & Hardt raised their price objective on shares of Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a report on Friday, July 28th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. Imperva currently has a consensus rating of “Hold” and a consensus price target of $52.34.

Shares of Imperva (IMPV) opened at 42.95 on Monday. The company has a 50-day moving average price of $44.09 and a 200-day moving average price of $45.85. Imperva has a 12 month low of $34.40 and a 12 month high of $57.24. The company’s market capitalization is $1.45 billion.

Imperva (NYSE:IMPV) last issued its quarterly earnings data on Thursday, July 27th. The software maker reported ($0.10) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.05 by ($0.15). Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The company had revenue of $74.44 million during the quarter, compared to analysts’ expectations of $74.30 million. During the same quarter last year, the business earned ($0.23) earnings per share. The business’s quarterly revenue was up 28.6% on a year-over-year basis. On average, equities analysts anticipate that Imperva will post $0.81 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This article was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://ledgergazette.com/2017/10/11/imperva-inc-impv-stock-rating-lowered-by-wells-fargo-company.html.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of the firm’s stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the sale, the director now owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.20% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in IMPV. ETF Managers Group LLC bought a new stake in shares of Imperva during the second quarter valued at approximately $41,888,000. North Run Capital LP increased its position in shares of Imperva by 999.3% during the first quarter. North Run Capital LP now owns 750,000 shares of the software maker’s stock valued at $30,788,000 after acquiring an additional 681,772 shares in the last quarter. Clearbridge Investments LLC increased its position in shares of Imperva by 47.0% during the first quarter. Clearbridge Investments LLC now owns 1,262,507 shares of the software maker’s stock valued at $51,826,000 after acquiring an additional 403,809 shares in the last quarter. BlackRock Inc. increased its position in shares of Imperva by 11.3% during the second quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock valued at $101,635,000 after acquiring an additional 215,170 shares in the last quarter. Finally, Eagle Asset Management Inc. increased its position in shares of Imperva by 17.7% during the second quarter. Eagle Asset Management Inc. now owns 1,279,848 shares of the software maker’s stock valued at $61,240,000 after acquiring an additional 192,625 shares in the last quarter. 92.72% of the stock is owned by institutional investors.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply